Bristol Myers Squibb (BMY) EPS (Diluted) (2009 - 2026)
Bristol Myers Squibb (BMY) posted EPS (Diluted) of $1.05 for Q3 2026, down 2.4% from $1.08 a year earlier and down 35.0% from the prior quarter.
Bristol Myers Squibb (BMY) EPS (Diluted) (2009 - 2026) Analysis & Trends
For the trailing twelve months through Sep 30, 2026, EPS (Diluted) at Bristol Myers Squibb was $4.50, up 52.0% year-over-year; for FY2025, it was $3.46.
- In prior years, Bristol Myers Squibb's EPS (Diluted) was -$4.41 in FY2024, $3.86 in FY2023 (+31.0%), $2.95 in FY2022 (-5.4%) and $3.12 in FY2021.
- Quarterly EPS (Diluted) has run from a low of -$5.89 in Q1 2024 to a high of $1.62 in Q2 2026 over five years.
- On a year-over-year basis, EPS (Diluted) increased in three of the last six quarters, with growth averaging 20.2%.
- The strongest year-over-year quarter for EPS (Diluted) in the past five years was Q2 2026, with growth of 152.0%; the weakest was Q4 2024, with a decline of 95.8%.
- According to Business Quant data, EPS (Diluted) for the three prior quarters was $1.62 (Q2 2026), $1.31 (Q1 2026) and $0.53 (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EPS (Diluted) (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,276.89 Bn | 1,250.50 Bn | 20.46 Bn | 7.22 |
| 2 | Johnson & Johnson | 681.31 Bn | 601.18 Bn | 17.30 Bn | 0.09 |
| 3 | AbbVie | 520.63 Bn | 488.64 Bn | 13.12 Bn | 2.38 |
| 4 | Merck | 357.22 Bn | 320.16 Bn | 13.19 Bn | 2.04 |
| 5 | Novartis Ag | 310.90 Bn | 284.14 Bn | - | - |
| 6 | Astrazeneca | 285.12 Bn | 258.77 Bn | 13.26 Bn | 2.00 |
| 7 | Amgen | 250.23 Bn | 201.89 Bn | 7.58 Bn | 7.08 |
| 8 | Gilead Sciences | 207.56 Bn | 182.67 Bn | 6.73 Bn | 1.94 |
| 9 | Pfizer | 164.42 Bn | 111.77 Bn | 12.56 Bn | 0.56 |
| 10 | Bristol Myers Squibb | 128.63 Bn | 83.82 Bn | 8.92 Bn | 1.05 |
Historic Data
| Date | Value |
|---|---|
| Sep 30, 2026 | 1.05 |
| Jun 30, 2026 | 1.62 |
| Mar 31, 2026 | 1.31 |
| Dec 31, 2025 | 0.53 |
| Sep 30, 2025 | 1.08 |
| Jun 30, 2025 | 0.64 |
| Mar 31, 2025 | 1.20 |
| Dec 31, 2024 | 0.04 |
| Sep 30, 2024 | 0.60 |
| Jun 30, 2024 | 0.83 |
| Mar 31, 2024 | -5.89 |
| Dec 31, 2023 | 0.85 |
| Sep 30, 2023 | 0.93 |
| Jun 30, 2023 | 0.99 |
| Mar 31, 2023 | 1.07 |
| Dec 31, 2022 | 0.94 |
| Sep 30, 2022 | 0.75 |
| Jun 30, 2022 | 0.66 |
| Mar 31, 2022 | 0.59 |
| Dec 31, 2021 | 1.06 |
Bristol Myers Squibb EPS (Diluted) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=eps-diluted&ticker=BMY&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "eps-diluted", "ticker": "BMY", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=eps-diluted&ticker=BMY&period=max&api_key=YOUR_API_KEY");
const data = await res.json();